{
    "info": {
        "nct_id": "NCT03693170",
        "official_title": "Phase II, Open-label, Single Arm, Multicenter Study of Encorafenib, Binimetinib Plus Cetuximab in Subjects With Previously Untreated BRAF V600E -Mutant Metastatic Colorectal Cancer",
        "inclusion_criteria": "* Male or female ≥ 18 years of age\n* Histologically or cytologically confirmed CRC that is metastatic\n* Presence of BRAF V600E in tumor tissue determined by local assay at any time prior to screening\n* Evidence of measurable disease as per RECIST, v1.1\n* Subject able to receive cetuximab as per approved label with regards to RAS status\n* Eastern Cooperative Oncology Group Status (ECOG) 0 or 1\n* Adequate renal, hepatic, cardiac and bone marrow functions and adequate electrolytes as per protocol\n* Subject able to take oral medications\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* Prior systemic therapy for metastatic disease\n* Prior treatment with any RAF inhibitor, MEK inhibitor, cetuximab or other anti-EGFR inhibitors\n* Symptomatic brain metastasis or Leptomeningeal disease\n* History or current evidence of Retinal Vein Occlusion (RVO) or current risk factors for RVO\n* History of chronic inflammatory bowel disease or Crohn's disease requiring medical intervention (immunomodulatory or immunosuppressive medications or surgery) ≤ 12 months prior to first dose.\n* Impaired cardiovascular function or clinically significant cardiovascular diseases: history of myocardial infarction or coronary disorders within 6 months prior to start of study treatment, symptomatic congestive heart failure (grade 2 or higher), past or current clinically significant arrhythmia and/or conduction disorder within 6 months prior to study treatment start\n* History of thromboembolic or cerebrovascular events within 6 months prior to start of study treatment\n* Concurrent neuromuscular disorder that is associated with potential elevation of Creatine Kinase\n* Known contraindication to cetuximab administration as per SPC/approved label",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subject able to receive cetuximab as per approved label with regards to RAS status",
            "criterions": [
                {
                    "exact_snippets": "able to receive cetuximab as per approved label with regards to RAS status",
                    "criterion": "RAS status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility for cetuximab per label",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Eastern Cooperative Oncology Group Status (ECOG) 0 or 1",
            "criterions": [
                {
                    "exact_snippets": "Eastern Cooperative Oncology Group Status (ECOG) 0 or 1",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 1,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Adequate renal, hepatic, cardiac and bone marrow functions and adequate electrolytes as per protocol",
            "criterions": [
                {
                    "exact_snippets": "Adequate renal ... functions",
                    "criterion": "renal function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Adequate ... hepatic ... functions",
                    "criterion": "hepatic function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Adequate ... cardiac ... functions",
                    "criterion": "cardiac function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Adequate ... bone marrow functions",
                    "criterion": "bone marrow function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "adequate electrolytes",
                    "criterion": "electrolyte levels",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Presence of BRAF V600E in tumor tissue determined by local assay at any time prior to screening",
            "criterions": [
                {
                    "exact_snippets": "Presence of BRAF V600E in tumor tissue",
                    "criterion": "BRAF V600E mutation in tumor tissue",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "determined by local assay",
                    "criterion": "BRAF V600E mutation determination method",
                    "requirements": [
                        {
                            "requirement_type": "determination method",
                            "expected_value": "local assay"
                        }
                    ]
                },
                {
                    "exact_snippets": "at any time prior to screening",
                    "criterion": "timing of BRAF V600E mutation determination",
                    "requirements": [
                        {
                            "requirement_type": "time of determination",
                            "expected_value": "any time prior to screening"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Histologically or cytologically confirmed CRC that is metastatic",
            "criterions": [
                {
                    "exact_snippets": "Histologically or cytologically confirmed CRC",
                    "criterion": "colorectal cancer (CRC)",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis confirmation method",
                            "expected_value": [
                                "histologically",
                                "cytologically"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "metastatic",
                    "criterion": "disease stage",
                    "requirements": [
                        {
                            "requirement_type": "stage",
                            "expected_value": "metastatic"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Male or female ≥ 18 years of age",
            "criterions": [
                {
                    "exact_snippets": "Male or female",
                    "criterion": "sex",
                    "requirements": [
                        {
                            "requirement_type": "allowed_values",
                            "expected_value": [
                                "male",
                                "female"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "≥ 18 years of age",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "age",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subject able to take oral medications",
            "criterions": [
                {
                    "exact_snippets": "Subject able to take oral medications",
                    "criterion": "ability to take oral medications",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Evidence of measurable disease as per RECIST, v1.1",
            "criterions": [
                {
                    "exact_snippets": "Evidence of measurable disease as per RECIST, v1.1",
                    "criterion": "measurable disease",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "assessment_method",
                            "expected_value": "RECIST v1.1"
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Prior treatment with any RAF inhibitor, MEK inhibitor, cetuximab or other anti-EGFR inhibitors",
            "criterions": [
                {
                    "exact_snippets": "Prior treatment with any RAF inhibitor",
                    "criterion": "prior treatment with RAF inhibitor",
                    "requirements": [
                        {
                            "requirement_type": "history of treatment",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Prior treatment with any ... MEK inhibitor",
                    "criterion": "prior treatment with MEK inhibitor",
                    "requirements": [
                        {
                            "requirement_type": "history of treatment",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Prior treatment with any ... cetuximab",
                    "criterion": "prior treatment with cetuximab",
                    "requirements": [
                        {
                            "requirement_type": "history of treatment",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Prior treatment with any ... other anti-EGFR inhibitors",
                    "criterion": "prior treatment with other anti-EGFR inhibitors",
                    "requirements": [
                        {
                            "requirement_type": "history of treatment",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Known contraindication to cetuximab administration as per SPC/approved label",
            "criterions": [
                {
                    "exact_snippets": "Known contraindication to cetuximab administration as per SPC/approved label",
                    "criterion": "contraindication to cetuximab",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "source",
                            "expected_value": "as per SPC/approved label"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Impaired cardiovascular function or clinically significant cardiovascular diseases: history of myocardial infarction or coronary disorders within 6 months prior to start of study treatment, symptomatic congestive heart failure (grade 2 or higher), past or current clinically significant arrhythmia and/or conduction disorder within 6 months prior to study treatment start",
            "criterions": [
                {
                    "exact_snippets": "Impaired cardiovascular function",
                    "criterion": "cardiovascular function",
                    "requirements": [
                        {
                            "requirement_type": "impairment",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "history of myocardial infarction ... within 6 months prior to start of study treatment",
                    "criterion": "myocardial infarction",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "time since event",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "coronary disorders within 6 months prior to start of study treatment",
                    "criterion": "coronary disorders",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "time since event",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "symptomatic congestive heart failure (grade 2 or higher)",
                    "criterion": "congestive heart failure",
                    "requirements": [
                        {
                            "requirement_type": "symptomatic",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "severity grade",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": ""
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "past or current clinically significant arrhythmia and/or conduction disorder within 6 months prior to study treatment start",
                    "criterion": "arrhythmia and/or conduction disorder",
                    "requirements": [
                        {
                            "requirement_type": "clinically significant",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "history or current",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "time since event",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of thromboembolic or cerebrovascular events within 6 months prior to start of study treatment",
            "criterions": [
                {
                    "exact_snippets": "History of thromboembolic ... events within 6 months prior to start of study treatment",
                    "criterion": "thromboembolic events",
                    "requirements": [
                        {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": "<=",
                                        "value": 6,
                                        "unit": "months"
                                    }
                                ]
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "History of ... cerebrovascular events within 6 months prior to start of study treatment",
                    "criterion": "cerebrovascular events",
                    "requirements": [
                        {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": "<=",
                                        "value": 6,
                                        "unit": "months"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History of chronic inflammatory bowel disease or Crohn's disease requiring medical intervention (immunomodulatory or immunosuppressive medications or surgery) ≤ 12 months prior to first dose.",
            "criterions": [
                {
                    "exact_snippets": "History of chronic inflammatory bowel disease",
                    "criterion": "chronic inflammatory bowel disease",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Crohn's disease requiring medical intervention (immunomodulatory or immunosuppressive medications or surgery) ≤ 12 months prior to first dose",
                    "criterion": "Crohn's disease requiring medical intervention",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "medical intervention type",
                            "expected_value": [
                                "immunomodulatory medications",
                                "immunosuppressive medications",
                                "surgery"
                            ]
                        },
                        {
                            "requirement_type": "time since intervention",
                            "expected_value": {
                                "operator": "<=",
                                "value": 12,
                                "unit": "months"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Symptomatic brain metastasis or Leptomeningeal disease",
            "criterions": [
                {
                    "exact_snippets": "Symptomatic brain metastasis",
                    "criterion": "brain metastasis",
                    "requirements": [
                        {
                            "requirement_type": "symptomatic",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Leptomeningeal disease",
                    "criterion": "leptomeningeal disease",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* History or current evidence of Retinal Vein Occlusion (RVO) or current risk factors for RVO",
            "criterions": [
                {
                    "exact_snippets": "History or current evidence of Retinal Vein Occlusion (RVO)",
                    "criterion": "Retinal Vein Occlusion (RVO)",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "current evidence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "current risk factors for RVO",
                    "criterion": "risk factors for Retinal Vein Occlusion (RVO)",
                    "requirements": [
                        {
                            "requirement_type": "current presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Prior systemic therapy for metastatic disease",
            "criterions": [
                {
                    "exact_snippets": "Prior systemic therapy for metastatic disease",
                    "criterion": "prior systemic therapy for metastatic disease",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Concurrent neuromuscular disorder that is associated with potential elevation of Creatine Kinase",
            "criterions": [
                {
                    "exact_snippets": "Concurrent neuromuscular disorder",
                    "criterion": "neuromuscular disorder",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "concurrent",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "associated with potential elevation of Creatine Kinase",
                    "criterion": "Creatine Kinase elevation",
                    "requirements": [
                        {
                            "requirement_type": "association_with_neuromuscular_disorder",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}